If you could vote on Brexit now which option would you choose?

Valneva expands trials on COVID-19 vaccine candidate

French vaccine maker Valneva (VLS.PA) is expanding trials of a COVID-19 vaccine candidate called VLA2001, and remains in talks with the European Commission over a potential contract, the company said on Thursday. Valneva shares plunged 42% after Britain said on Sept 13 that it cancelled its contract for about 100 million doses of the vaccine the company is developing, partly over concerns about when it would win approval for use.

Reuters - September 23, 2021

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/valneva-expands-trials-covid-19-vaccine-candidate-2021-09-23/